131 related articles for article (PubMed ID: 3055414)
1. Fibrin activatable urokinase (FA-UK): a latent form of UK found in urine related to a complex with an inhibitor/fibrin-interacting cofactor.
Dwivedi C; Pannell R; Gurewich V
Thromb Res; 1988 Jul; 51(2):197-208. PubMed ID: 3055414
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of single-chain urokinase (pro-urokinase) by thrombin and thrombin-like enzymes: relevance of the findings to the interpretation of fibrin-binding experiments.
Gurewich V; Pannell R
Blood; 1987 Mar; 69(3):769-72. PubMed ID: 2949785
[TBL] [Abstract][Full Text] [Related]
3. The pH dependence of the binding of pro-urokinase to fibrin/celite.
Pannell R; Angles-Cano E; Gurewich V
Thromb Haemost; 1990 Dec; 64(4):556-8. PubMed ID: 2128139
[TBL] [Abstract][Full Text] [Related]
4. Activation of plasminogen by single-chain urokinase or by two-chain urokinase--a demonstration that single-chain urokinase has a low catalytic activity (pro-urokinase).
Pannell R; Gurewich V
Blood; 1987 Jan; 69(1):22-6. PubMed ID: 3790724
[TBL] [Abstract][Full Text] [Related]
5. Fibrin-binding urokinase (or precursor form of urokinase) with a molecular weight of about 100,000 in fresh human urine.
Sumi H; Tsushima H; Maruyama M; Mihara H
Enzyme; 1985; 34(4):201-11. PubMed ID: 2941273
[TBL] [Abstract][Full Text] [Related]
6. Pro-urokinase: a study of its stability in plasma and of a mechanism for its selective fibrinolytic effect.
Pannell R; Gurewich V
Blood; 1986 May; 67(5):1215-23. PubMed ID: 3083889
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of the efficacy and specificity of tissue plasminogen activator and pro-urokinase: demonstration of synergism and of different thresholds of non-selectivity.
Gurewich V; Pannell R
Thromb Res; 1986 Oct; 44(2):217-28. PubMed ID: 3097872
[TBL] [Abstract][Full Text] [Related]
8. Effective and fibrin-specific clot lysis by a zymogen precursor form of urokinase (pro-urokinase). A study in vitro and in two animal species.
Gurewich V; Pannell R; Louie S; Kelley P; Suddith RL; Greenlee R
J Clin Invest; 1984 Jun; 73(6):1731-9. PubMed ID: 6725557
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of the promotion of tissue plasminogen activator and pro-urokinase-induced plasminogen activation by fragments D and E-2 of fibrin.
Liu JN; Gurewich V
J Clin Invest; 1991 Dec; 88(6):2012-7. PubMed ID: 1836471
[TBL] [Abstract][Full Text] [Related]
10. Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin.
Müllertz S
Biochem J; 1974 Nov; 143(2):273-83. PubMed ID: 4282470
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a recombinant chimeric plasminogen activator with enhanced fibrin binding.
Jiao J; Yu M; Ru B
Biochim Biophys Acta; 2001 Apr; 1546(2):399-405. PubMed ID: 11295444
[TBL] [Abstract][Full Text] [Related]
12. Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained.
Pannell R; Black J; Gurewich V
J Clin Invest; 1988 Mar; 81(3):853-9. PubMed ID: 2963831
[TBL] [Abstract][Full Text] [Related]
13. Fragment E-2 from fibrin substantially enhances pro-urokinase-induced Glu-plasminogen activation. A kinetic study using the plasmin-resistant mutant pro-urokinase Ala-158-rpro-UK.
Liu JN; Gurewich V
Biochemistry; 1992 Jul; 31(27):6311-7. PubMed ID: 1385727
[TBL] [Abstract][Full Text] [Related]
14. Transport of urokinase across the intestinal tract of normal human subjects with stimulation of synthesis and/or release of urokinase-type proteins.
Toki N; Sumi H; Sasaki K; Boreisha I; Robbins KC
J Clin Invest; 1985 Apr; 75(4):1212-22. PubMed ID: 3921568
[TBL] [Abstract][Full Text] [Related]
15. Plasminogen activator inhibitor from human fibrosarcoma cells binds urokinase-type plasminogen activator, but not its proenzyme.
Andreasen PA; Nielsen LS; Kristensen P; Grøndahl-Hansen J; Skriver L; Danø K
J Biol Chem; 1986 Jun; 261(17):7644-51. PubMed ID: 3086313
[TBL] [Abstract][Full Text] [Related]
16. Single-chain urokinase-type plasminogen activator does not possess measurable intrinsic amidolytic or plasminogen activator activities.
Husain SS
Biochemistry; 1991 Jun; 30(23):5797-805. PubMed ID: 1828371
[TBL] [Abstract][Full Text] [Related]
17. Characterization and fibrin-binding properties of different molecular forms of pro-urokinase from a monkey kidney cell culture.
Wijngaards G; Rijken DC; van Wezel AL; Groeneveld E; van der Velden CA
Thromb Res; 1986 Jun; 42(6):749-60. PubMed ID: 3088754
[TBL] [Abstract][Full Text] [Related]
18. Activation of fibrin-bound plasminogen by pro-urokinase and its complementariness with that by tissue plasminogen activator.
Gurewich V
Enzyme; 1988; 40(2-3):97-108. PubMed ID: 2971533
[TBL] [Abstract][Full Text] [Related]
19. Tissue plasminogen activator and urokinase mediate the binding of Glu-plasminogen to plasma fibrin I. Evidence for new binding sites in plasmin-degraded fibrin I.
Harpel PC; Chang TS; Verderber E
J Biol Chem; 1985 Apr; 260(7):4432-40. PubMed ID: 3156857
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the intrinsic fibrinolytic properties of pro-urokinase through a study of plasmin-resistant mutant forms produced by site-specific mutagenesis of lysine(158).
Gurewich V; Pannell R; Broeze RJ; Mao J
J Clin Invest; 1988 Dec; 82(6):1956-62. PubMed ID: 2974047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
